Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial.
Takamochi K, Haruki T, Oh S, Endo M, Funai K, Kitamura Y, Tsuboi M, Tsukioka T, Suzuki H, Ito H, Okumura N, Ueno T, Ikeda N, Iwata H, Okada M, Ichikawa T, Okamoto T, Nojiri S, Suzuki K; Advanced Clinical Trial Chest Surgery Group. Takamochi K, et al. Among authors: okumura n. J Thorac Cardiovasc Surg. 2024 Aug;168(2):401-410.e1. doi: 10.1016/j.jtcvs.2023.10.050. Epub 2023 Oct 30. J Thorac Cardiovasc Surg. 2024. PMID: 38348845 Clinical Trial.
Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M, Date H, Wada H, Okubo K, Hamakawa H, Teramukai S, Matsumura A, Nakagawa T, Sumitomo S, Miyamoto Y, Okumura N, Takeo S, Kawakami K, Aoki M, Kosaka S; The Japan-Multinational Trial Organization. Sonobe M, et al. Among authors: okumura n. J Thorac Cardiovasc Surg. 2013 Oct;146(4):788-95. doi: 10.1016/j.jtcvs.2013.04.043. Epub 2013 Jun 27. J Thorac Cardiovasc Surg. 2013. PMID: 23810113 Free article.
A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
Saji H, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, Miyazaki T, Aokage K, Nakao M, Haruki T, Ito H, Kataoka K, Okabe K, Tomizawa K, Yoshimoto K, Horio H, Sugio K, Ode Y, Takao M, Okada M, Chida M; Committee for Scientific Affairs, The Japanese Association for Chest Surgery, Tokyo, Japan. Saji H, et al. Among authors: okumura n. Eur J Cardiothorac Surg. 2018 Apr 1;53(4):835-841. doi: 10.1093/ejcts/ezx415. Eur J Cardiothorac Surg. 2018. PMID: 29240884
A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer.
Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Tada H, Kajiwara S, Watanabe N, Okada M, Sakamoto J, Aoe M, Soh J, Miyoshi S, Hotta K, Matsuo K, Date H. Toyooka S, et al. Among authors: okumura n. J Thorac Oncol. 2018 May;13(5):699-706. doi: 10.1016/j.jtho.2018.02.015. Epub 2018 Mar 2. J Thorac Oncol. 2018. PMID: 29505900 Free article. Clinical Trial.
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR).
Sakai K, Tsuboi M, Kenmotsu H, Yamanaka T, Takahashi T, Goto K, Daga H, Ohira T, Ueno T, Aoki T, Nakagawa K, Yamazaki K, Hosomi Y, Kawaguchi K, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Saeki S, Sugio K, Nishio M, Okabe K, Yamamoto N, Nishio K. Sakai K, et al. Among authors: okumura n. Cancer Sci. 2021 Jan;112(1):388-396. doi: 10.1111/cas.14730. Epub 2020 Nov 30. Cancer Sci. 2021. PMID: 33185928 Free PMC article. Clinical Trial.
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
Okumura N, Soh J, Suzuki H, Nakata M, Fujiwara T, Nakamura H, Sonobe M, Fujinaga T, Kataoka K, Gemba K, Kataoka M, Hotta K, Yoshioka H, Matsuo K, Sakamoto J, Date H, Toyooka S. Okumura N, et al. BMC Cancer. 2021 May 6;21(1):506. doi: 10.1186/s12885-021-08232-6. BMC Cancer. 2021. PMID: 33957881 Free PMC article. Clinical Trial.
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapy.
Takahashi T, Sakai K, Kenmotsu H, Yoh K, Daga H, Ohira T, Ueno T, Aoki T, Hayashi H, Yamazaki K, Hosomi Y, Chen-Yoshikawa TF, Okumura N, Takiguchi Y, Sekine A, Haruki T, Yamamoto H, Sato Y, Akamatsu H, Seto T, Saeki S, Sugio K, Nishio M, Inokawa H, Yamamoto N, Nishio K, Tsuboi M. Takahashi T, et al. Among authors: okumura n. Cancer Sci. 2022 Jan;113(1):287-296. doi: 10.1111/cas.15171. Epub 2021 Nov 7. Cancer Sci. 2022. PMID: 34689382 Free PMC article. Clinical Trial.
757 results